Globalive Media
Beyond Innovation: Episode 24
AI learns to brew beer, robots run an indoor farm and technology starves cancer cells into submission. Plus, Michael and Anthony speak with a LinkedIn co-founder about platforms transforming everyday tasks. Hosted by venture capitalist...
Globalive Media
Beyond Innovation: Episode 21
An algorithm becomes a book critic, a robot imitates a fruit fly and a startup pioneers a new way to fight cancer. Plus, Michael and Anthony speak with prolific inventor Nathan Myhrvold about metamaterials that possess strange yet useful...
AllTime 10s
10 Times The World Almost Ended By Accident
Humanity is a clumsy species. How else can you explain all the times we've almost fumbled our way into extinction. From nuclear false alarms to poisoned crops, here are 10 Times The World Almost Ended By Accident.
Globalive Media
Beyond Innovation: Episode 1
The Internet-of-Things connects everything, nanotechnology heals damaged brains and a venture capitalist spots medical breakthroughs. Plus, Anthony and Michael speak with David Hanson, the pioneering roboticist behind some of the most...
Bloomberg
Biopharma's Tech Adoption Challenges
Life sciences-focused cloud startup Benchling has seen its business soar over the last few years, amid a renewed interest in biotech among investors. Benchling CEO Sajith Wickramasekara joins Caroline Hyde and Ed Ludlow to discuss the...
Bloomberg
B Capital's Ganguly on SE Asia Investment Opportunities
Raj Ganguly, Co-founder and Partner at B Capital, discusses the investment opportunities in Southeast Asia and tech startups. He speaks with Shery Ahn and Haidi Stroud-Watts on "Bloomberg Daybreak: Asia".
Bloomberg
S&P 500 E-Mini Futures Going Higher, 3D Capital's Dugan Says
Apr.18 -- On this edition of "Charting Futures," 3D Capital Management's Eric Dugan examines S&P 500 e-mini futures with Bloomberg's Abigail Doolittle on "Bloomberg Markets: The Close."
Bloomberg
The MIT Media Lab's Next Breakthrough
May 11 -- Joi Ito, MIT Media Lab director, discusses the new environment for tech startups with Bloomberg's Emily Chang on "Bloomberg West."
Bloomberg
Reshaping the Pharma Industry
June 28 -- Jami Rubin, partner at Goldman Sachs, discusses the impact of Brexit on the pharmaceutical industry, research and development in the sector and companies she's keeping an eye on. She speaks to Bloomberg's Joe Weisenthal, Matt...
Bloomberg
How to Find the Most Popular Trades on Robinhood
Jul.23 -- The site that tracks trading activity at retail brokerage Robinhood has attracted the attention of Wall Street. Hedge funds and other traders are looking to aggregate Robintrack.net data that shows how many accounts own any...
Bloomberg
Novavax Vaccine Will Probably Work on New Covid Strain: CEO
Dec.28 -- Novavax Inc. Chief Executive Officer Stan Erck discusses the phase 3 trial of the company's Covid-19 vaccine and says the data so far have been at or above the levels of Moderna Inc. and Pfizer Inc. He speaks with Bloomberg's...
Bloomberg
Julius Baer's Matthews Favors Commodity Firms, Biotech, PE
Mark Matthews, head of Asia research at Bank Julius Baer & Co. Ltd., discusses the sanctions imposed on Russia for its war with Ukraine and how those sanctions could impact global markets. He speaks on "Bloomberg Daybreak: Asia."
Bloomberg
Future Vaccines Have 'High Barrier' to Cross, Vir CEO Says
Dec.04 -- Vir Biotechnology Inc. Chief Executive Officer George Scangos says the manufacturing of vaccines is a highly regulated, complex process and the capacity to make drugs for Covid-19 is "somewhat limited." He speaks on "Bloomberg...
Bloomberg
Centene CEO Doubts Medicare-for-All Will Happen
Dec.18 -- Michael Neidorff, Centene Corp. chief executive officer, says the company will stick to its business strategy and expresses confidence it will prevail during the Covid-19 pandemic. He speaks on "Bloomberg Markets: The Close."
Bloomberg
Split Personality: How a Divided Congress May Hit Banks, Tech & Pharma
Nov.05 -- With a divided U.S. Congress, analysts think bank and pharmaceutical stocks could come out relatively unharmed, or even supported, if Democrats cause gridlock with Donald Trump's agenda. But the pain could continue for tech and...
Bloomberg
Market Winners and Losers in a Trump Presidency
Nov. 9 -- Kate Moore, chief equity strategist at BlackRock, examines the potential market winners and losers of a Donald Trump presidency. She speaks on "Bloomberg Daybreak: Americas."
Bloomberg
Capital Link CEO on Asia Markets Outlook
Brett McGonegal, Chairman and CEO at Capital Link, discusses his outlook for Asia markets and strategy. He speaks with Shery Ahn and Haidi Stroud-Watts on "Bloomberg Daybreak: Asia".
Bloomberg
2016: Biotech’s Tumultuous Year
Dec.30 -- Bloomberg’s Doni Bloomfield discusses his 2017 outlook for the biotech sector on “Bloomberg Markets.â€
Bloomberg
Why Biotech's $20B Merger Monday May Not Be a Home Run
Jan.22 -- Bloomberg Gadfly columnist Max Nisen discusses Celgene's $9 billion buyout of Juno Therapeutics and Sanofi's $11.6 billion deal for Bioverativ on "Bloomberg Markets." (Nisen is a Bloomberg Gadfly columnist. The opinions...
Bloomberg
Corteva CEO Sees 'Tremendous' Amount of Demand After DuPont Separation
Jun.03 -- James Collins, Corteva Agriscience chief executive officer, discusses the company's separation from DowDuPont Inc. with Bloomberg's Vonnie Quinn and Ed Hammond on "Bloomberg Markets."
Bloomberg
Very Close to EU Budget Deal: European Investment Bank’s Hoyer
Nov.10 -- Werner Hoyer, president at European Investment Bank, discusses the European economy, the potential for a coronavirus vaccine, its impact on investment and the EU budget deal. He speaks on “Bloomberg Markets: European Open.”
Bloomberg
Lightspeed Raises $7 Billion Across Four Funds
Lightspeed Venture Partners Partner Bejul Somaia speaks with Emily Chang about raising $7 billion across four new funds, where the company is planning to deploy capital, which founders and regions it's focusing on, and the debut of...
Bloomberg
Nasdaq CEO Friedman Sees Healthy IPO Pipeline Going Into Fall
Jul.24 -- Nasdaq CEO Adena Friedman discusses the health of the IPO market on "Bloomberg Markets: The Close."
Bloomberg
Bristol Myers Plans to Launch Nine New Drugs, CEO Says
Bristol Myers Squibb Chairman and CEO Dr. Giovanni Caforio expects the company's new drugs to generate $10 billion to $13 billion in sales by 2025 and adds that the drugmaker is also looking at small and mid-size bolt-on deals to add to...